Waldencast Acquisition Corp. ( (WALD) ) has released its Q2 earnings. Here is a breakdown of the information Waldencast Acquisition Corp. presented to its investors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Waldencast Acquisition Corp. is a global multi-brand beauty and wellness platform focused on developing, acquiring, and scaling purpose-driven brands in the beauty industry. In the first half of 2025, Waldencast reported significant progress in its strategic priorities, with Obagi Medical achieving double-digit growth in its core channels and Milk Makeup showing strong retail sales performance in the U.S. The company also announced the acquisition of Novaestiq, which doubles Obagi Medical’s addressable market in the U.S. and marks its entry into the aesthetics space. Despite challenges in international markets and supply chain issues, the company remains optimistic about its future growth, updating its full-year guidance to reflect a more moderated industry environment. Waldencast is undertaking a strategic review to explore alternatives for enhancing shareholder value, while continuing to focus on executing its business strategy and addressing the dynamic beauty market’s needs.